These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7164412)

  • 21. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD; Terry JM
    Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fibrinogen-fibrin degradation products in diabetes mellitus].
    Alakhverdian R; Koev D
    Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
    Lo MK; Lee KF; Chan NN; Leung WY; Ko GT; Chan WB; So WY; Ng MC; Ho CS; Tam JS; Lam CW; Tong PC; Chan JC
    Diabetes Obes Metab; 2004 May; 6(3):223-30. PubMed ID: 15056131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cardiovascular changes among deceased patients with diabetes mellitus and diabetic nephropathy among 9015 autopsied over the age of 14].
    Stefanov G; Minkova V; Vretenarska M; Bŭnkova M
    Vutr Boles; 1983; 22(4):53-9. PubMed ID: 6675284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombin III and fibrinogen degradation product (fragment E) in diabetic nephropathy.
    Chan V; Yeung CK; Chan TK
    J Clin Pathol; 1982 Jun; 35(6):661-6. PubMed ID: 7085916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical importance of the radioimmunologic determination of beta 2-microglobulin in patients with kidney pathology].
    Trusov VV; Filimonov MA; Kazakova IA; Marizin SA
    Ter Arkh; 1988; 60(11):117-20. PubMed ID: 2907187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum fibrinogen/fibrin degradation products in patients with ovarian carcinoma.
    Lalos O; Frankendal B; Rudolphi O
    Ann Chir Gynaecol; 1977; 66(3):131-134. PubMed ID: 327909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes].
    Qin LX; Zeng X; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):208-11. PubMed ID: 16145917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombin III deficiency in diabetes mellitus: influence on vascular degenerative complications.
    Monnier L; Follea G; Mirouze J
    Horm Metab Res; 1978 Nov; 10(6):470-3. PubMed ID: 744566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intraglomerular coagulation in patients with glomerulonephritis, with special reference to FDP D-dimer].
    Shibata T; Ura S; Hirai Y; Taura K; Harada T; Hara K
    Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1143-9. PubMed ID: 6663183
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
    Di Cesare E; Quartarone M; Cucinotta D; Coppolino E; Squadrito G
    Minerva Med; 1979 May; 70(22):1597-9. PubMed ID: 450299
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic renal disease in diabetic and prediabetic subjects: a community-based study in Shanghai].
    Wang WX; Jia WP; Bao YQ; Lu JX; Lu HJ; Zuo YH; Du J; Liu LH; Fang R; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2527-32. PubMed ID: 17198559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary fibrin (-ogen) degradation products in Russell's viper (Daboia russelii siamensis) bite victims.
    Han KE; Than T; Lwin M; Swe TN; Pe T
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):198-201. PubMed ID: 8362297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in blood coagulation in diabetic nephropathy].
    Astrug A; Khristov L; Stamenova T
    Vutr Boles; 1975; 14(4):69-75. PubMed ID: 1224599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.